Virtu Financial’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,958
Closed -$57K 1597
2023
Q4
$57K Buy
+12,958
New +$51.9K ﹤0.01% 1154
2023
Q2
Sell
-17,380
Closed -$67K 1660
2023
Q1
$67K Sell
17,380
-171
-1% -$623 0.01% 1053
2022
Q4
$49K Buy
17,551
+351
+2% +$944 0.01% 1087
2022
Q3
$36K Sell
17,200
-8,411
-33% -$20.9K ﹤0.01% 1275
2022
Q2
$67K Buy
+25,611
New +$85.9K 0.01% 1043

Other funds holding ETON

Virtu Financial's ETON Position: Q1 2024 in Review

Virtu Financial sold out of Eton Pharmaceutcials (ETON) in Q1 2024, closing a stake of 12,958 shares — an estimated $57K sold.

Virtu Financial first reported a position in ETON in Q2 2022 and held it in 5 quarters. The position peaked at $67K in Q1 2023. 44 funds tracked by Wall St. Rank hold ETON as of Q1 2024.

  • Virtu Financial reported no remaining Eton Pharmaceutcials position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 12,958 Eton Pharmaceutcials shares in Q1 2024, an estimated $57K.
  • Virtu Financial first reported a position in Eton Pharmaceutcials in Q2 2022 and held it in 5 quarters.
  • Virtu Financial's Eton Pharmaceutcials position peaked at $67K in Q1 2023.
  • 44 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.